Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    80.0%

    Based on 4 completed trials

    Completion Rate
    80%(4/5)
    Active Trials
    0(0%)
    Results Posted
    25%(1 trials)
    Terminated
    1(17%)

    Phase Distribution

    Not Applicable
    2
    33%
    Phase 3
    1
    17%
    Phase 2
    1
    17%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    1

    Late Stage

    Phase Distribution4 total trials
    Phase 2Efficacy & side effects
    1(25.0%)
    Phase 3Large-scale testing
    1(25.0%)
    N/ANon-phased studies
    2(50.0%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    66.7%

    4 of 6 finished

    Non-Completion Rate

    33.3%

    2 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    6

    all time

    Status Distribution
    Completed(4)
    Terminated(2)

    Detailed Status

    Completed4
    Terminated1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    6
    Active
    0
    Success Rate
    80.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 21 (25.0%)
    Phase 31 (25.0%)
    N/A2 (50.0%)

    Trials by Status

    terminated117%
    withdrawn117%
    completed467%

    Recent Activity

    0 active trials
    Showing 5 of 6
    completed

    Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

    NCT00688246
    completednot_applicable

    Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

    NCT00892515
    completedphase_3

    Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

    NCT00354302
    terminatedphase_2

    Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

    NCT00634582
    withdrawnnot_applicable

    Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

    NCT00996749
    View all 6 trials

    Clinical Trials (6)

    Showing 6 of 6 trials
    NCT00688246

    Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

    Completed
    NCT00892515Not Applicable

    Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer

    Completed
    NCT00354302Phase 3

    Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

    Completed
    NCT00634582Phase 2

    Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases

    Terminated
    NCT00996749Not Applicable

    Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

    Withdrawn
    NCT00458588

    Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

    Completed

    All 6 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    6